Anti IL-6 therapies function by inhibiting the action of IL-6, thereby reducing inflammation and modulating the immune response. These therapies can involve monoclonal antibodies that specifically target IL-6 or its receptor, blocking the cytokine's ability to bind and activate immune cells.
